Report Categories Report Categories

Report Categories

industry Category

All

Total: 2 records, 1 pages

Global Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 14 Dec 2024

date Medical Care

new_biaoQian Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service

Mesenchymal stem cell (MSCs) therapeutic product CDMO (Contract Development and Manufacturing Organization) services refer to a series of services from research and development to production for mesenchymal stem cell-related therapeutic products. CDMOs usually provide outsourcing services to pharmaceutical and biotechnology companies to help them develop and produce biologics in the preclinical and clinical stages.

USD3480.00

Add To Cart

Add To Cart

Global Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Supply, Demand and Key Producers, 2024-2030

date 14 Dec 2024

date Medical Care

new_biaoQian Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service

Mesenchymal stem cell (MSCs) therapeutic product CDMO (Contract Development and Manufacturing Organization) services refer to a series of services from research and development to production for mesenchymal stem cell-related therapeutic products. CDMOs usually provide outsourcing services to pharmaceutical and biotechnology companies to help them develop and produce biologics in the preclinical and clinical stages.

USD4480.00

Add To Cart

Add To Cart

Mesenchymal stem cell (MSCs) therapeutic product CDMO (Contract Development and Manufacturing Organization) services refer to a series of services from research and development to production for mesenchymal stem cell-related therapeutic products. CDMOs usually provide outsourcing services to pharmaceutical and biotechnology companies to help them develop and produce biologics in the preclinical and clinical stages.

USD3480.00

addToCart

Add To Cart

Mesenchymal stem cell (MSCs) therapeutic product CDMO (Contract Development and Manufacturing Organization) services refer to a series of services from research and development to production for mesenchymal stem cell-related therapeutic products. CDMOs usually provide outsourcing services to pharmaceutical and biotechnology companies to help them develop and produce biologics in the preclinical and clinical stages.

USD4480.00

addToCart

Add To Cart